Humana warns of ‘uncertainty’ in medical usage amid rising COVID-19 cases
Dive Brief: Non-COVID-19 medical use bounced back faster than expected during the second quarter, Humana executives told investors Wednesday. The insurer was able to post net income of $ 588 million as COVID-19 treatment costs for its members fell faster than anticipated, compared to $ 1.8 billion a year ago as patients deferred care amid the… Read More »
